Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Robert E. Nordquist"'
Publikováno v:
Journal of Innovative Optical Health Sciences, Vol 9, Iss 1, Pp 1630001-1-1630001-11 (2016)
Photonics immunotherapy is a novel cancer treatment strategy that combines local phototherapy and immunotherapy. Phototherapy is a noninvasive or minimally invasive therapeutic strategy for local treatment of cancer, which can destroy tumor cells and
Externí odkaz:
https://doaj.org/article/cc65a00c5a1047d6baa1e74f65164ec0
Autor:
Xiaosong Li, Min Min, Nan Du, Ying Gu, Tomas Hode, Mark Naylor, Dianjun Chen, Robert E. Nordquist, Wei R. Chen
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
With the development of cancer immunotherapy, cancer vaccine has become a novel modality for cancer treatment, and the important role of adjuvant has been realized recently. Chitin, chitosan, and their derivatives have shown their advantages as adjuv
Externí odkaz:
https://doaj.org/article/67eecdea340144d4b8fc1c17c139ab8b
Autor:
Jie Rao, Miao Wang, Wei R. Chen, Robert E. Nordquist, Meng Wang, Feifan Zhou, Kaili Liu, Xiaosong Li, Mark F. Naylor
Publikováno v:
Theranostics
Targeted therapy and immunotherapy in combination is considered the ideal strategy for treating metastatic cancer, as it can eliminate the primary tumors and induce host immunity to control distant metastases. Phototherapy, a promising targeted thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1573c4aaa6148c552f136d5efa162799
https://doi.org/10.7150/thno.53056
https://doi.org/10.7150/thno.53056
Autor:
Yong Li, Feifan Zhou, Robert E. Nordquist, Wei R. Chen, Connor L. West, Austin Doughty, Lu Wang, Xiaosong Li
Publikováno v:
Nanomedicine
Metastasis is the major cause of cancer-death. Checkpoint inhibition shows great promise as an immunotherapeutic treatment for cancer patients. However, most currently available checkpoint inhibitors have low response rates. To augment the antitumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38599f2e64ff28bd4fb595c2c7c6963d
https://doi.org/10.1016/j.nano.2019.02.009
https://doi.org/10.1016/j.nano.2019.02.009
Publikováno v:
Journal of Biophotonics. 10:618-622
Immunotherapy has become a promising modality for melanoma, especially using checkpoint inhibitors, which revive suppressed T cells against the cancer. Such inhibitors should work better when combined with other treatments which could increase the nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bed0819ece65be838a4b667b18c93011
https://doi.org/10.1002/jbio.201600271
https://doi.org/10.1002/jbio.201600271
Publikováno v:
Biophotonics and Immune Responses XIV.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::219ffc1992a2efd3f29cde750016d555
https://doi.org/10.1117/12.2510982
https://doi.org/10.1117/12.2510982
Autor:
Mark F. Naylor, Tomas Hode, Samuel S.K. Lam, Xiaosong Li, Robert E. Nordquist, Luciano Alleruzzo, Wei R. Chen, Feifan Zhou, Lei Shi, Xiuli Wang, Nan Du, Joseph Raker
Publikováno v:
Cancer Letters. 359:169-177
A novel, promising potential cancer vaccine strategy was proposed to use a two-injection procedure for solid tumors to prompt the immune system to identify and systemically eliminate the primary and metastatic cancers. The two-injection procedure con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d213987283fbbace6675fe7cebaa27a
https://doi.org/10.1016/j.canlet.2015.01.029
https://doi.org/10.1016/j.canlet.2015.01.029
Autor:
Wei R. Chen, Tomas Hode, Samuel Siu Kit Lam, Joseph Raker, Robert E. Nordquist, Luciano Alleruzzo
Publikováno v:
Biophotonics and Immune Responses XI.
A novel method, an in situ autologous whole-cell cancer vaccine (inCVAX), is being developed by Immunophotonics, Inc., for the treatment of metastatic cancers. inCVAX combines phototherapy and immunotherapy to potentially induce a systemic anti-tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d488c2e4010cbfe1b923da73580093d3
https://doi.org/10.1117/12.2216110
https://doi.org/10.1117/12.2216110
Publikováno v:
SPIE Proceedings.
Clinical trials of late-stage breast cancer patients and late-stage melanoma patients treated by laser immunotherapy (LIT) have shown promising results. In a 2010 study of Li et al, eleven late-stage melanoma patients received LIT in one or multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::072d99433d0258769958925bf72dba35
https://doi.org/10.1117/12.2213891
https://doi.org/10.1117/12.2213891
Autor:
Wei R. Chen, Du Nan, Tomas Hode, Eric W. Howard, Roman F. Wolf, Robert E. Nordquist, J. A. Lunn, Min Min, Gu Ying, Li Xiaosong, O. Adalsteinsson
Publikováno v:
IEEE Journal of Selected Topics in Quantum Electronics. 18:1434-1438
Laser immunotherapy (LIT) is an in situ autologous cancer vaccine (inCVAX) that induces a systemic immune responses through a local intervention. The effect of LIT depends on two major interactions: a selective photothermal interaction and an active
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aae5c710c9681e8f5444efb565af2aa7
https://doi.org/10.1109/jstqe.2011.2182183
https://doi.org/10.1109/jstqe.2011.2182183